Noven Pharmaceuticals Inactive 10-Q2009 Q1 Quarterly report

Filed: 11 May 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: acquiree, ARB, attractive, aware, bargain, Bulletin, central, channel, clarify, classification, CNS, compound, consummated, decision, deconsolidation, distinct, enable, equivalent, European, fall, formal, gain, inactive, inactivity, increasingly, installment, lapse, length, liable, MAA, Medicare, model, noncontrolling, nonperformance, notified, Notwithstanding, objective, Oregon, organizational, persist, population, portfolio, primary, psychiatric, redeemed, redemption, reinvestment, relationship, reliably, retrospectively, solution, Southern, Taxation, true, type, unprofitable, veto, viewed

Removed: acceptable, accounted, administration, advanced, advancing, affiliate, amphetamine, anniversary, anticipated, appointment, area, auditing, awarded, backlog, base, bipolar, brand, branded, Brandt, capitalized, caption, category, Center, clear, collateralized, CombiPatch®increase, CombiPatch®increased, consecutive, corrective, dated, declared, deductible, deferral, depending, derivative, derive, discretion, Dutch, earlier, Eisenberg, eligible, employee, employment, encouraged, ending, enforcement, entitled, epilepsy, equal, excluding, exit, expensed, fail, filled, finite, floating, Florida, Food, formed, forwarded, funded, greater, guaranteed, half, hedged, hedging, hold, impacted, incorporation, indirectly, influencing, infrastructure, initial, investor, Jeffrey, largely, lesser, leverage, liquid, liquidate, marketplace, maximum, measurement, measuring, mechanism, menopause, migraine, minima, monetary, monitor, municipal, nominal, nonrecurring, observable, occurring, office, operation, orderly, overview, owed, payable, Peter, prescribing, professional, profitable, promotional, psychiatry, quoted, rated, realizing, reducing, reset, resolution, retained, rollover, running, satisfactorily, separation, shipped, slightly, step, student, submission, sustained, tangible, targeted, temporary, term, terminated, thisForm, threshold, twelve, typically, unrelated, vasomotor, Vice

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Noven Pharmaceuticals similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

In connection with the Form 10-Q of Noven Pharmaceuticals, Inc. (“Noven”) for the quarter ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Brandt, President and Chief Executive Officer of Noven, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	1)		the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

	2)		the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Noven.


/s/ Peter Brandt
Name: Peter Brandt
Title: President and Chief Executive Officer
Date: May 11, 2009